Professor Sarah Wordsworth joined the Health Economics Research Centre in January 2003 and developed a research programme on the economics of genetic and genomic technologies, which in particular explores the economics of translating high-throughput sequencing technologies such as whole-genome sequencing in rare diseases and cancer into health care systems.

Her other research interests include antimicrobial resistance. She also addresses methodological challenges in trial-based economic evaluations in the areas of surgery for obesity, lung cancer surgery, cardiovascular disease and eye disease.
Sarah undertakes policy work and leads the Health Economics Genomics England Clinical Interpretation Partnership (GeCIP). for the UK’s 100,000 Genomes Project.

As a Senior Fellow at St Anne’s College, Sarah is a member of the college Governing Body and graduate advisor for DPhil and MSc students.